Evidence map›Paper›PMID 31152240›Full record

ArticlePflugers Archiv : European journal of physiology2019

Chronic AICAR treatment prevents metabolic changes in cardiomyocytes exposed to free fatty acids.

Christelle Viglino, Bernard Foglia, Christophe Montessuit

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. NADMetabolites · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Relationships between constituents of energy drinks and beating parameters in human induced pluripotent stem cell (iPSC)-Derived cardiomyocytes.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2021
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christelle ViglinoDepartment of Pathology and Immunology, University of Geneva School of Medicine, 1 Michel-Servet Street, 1211, Geneva 4, Switzerland.
Bernard FogliaDepartment of Pathology and Immunology, University of Geneva School of Medicine, 1 Michel-Servet Street, 1211, Geneva 4, Switzerland.
Christophe MontessuitDepartment of Pathology and Immunology, University of Geneva School of Medicine, 1 Michel-Servet Street, 1211, Geneva 4, Switzerland. christophe.montessuit@unige.ch.ORCID 0000-0002-2580-7711
University of Geneva · CH

Funding

Swiss National Science Foundation 310030_146537
6 · The paper itself

Abstract

The stimulation of glucose transport by metabolic stress is an important determinant of myocardial susceptibility to ischemia and reperfusion injury. Stimulation of glucose transport is markedly impaired in cardiomyocytes chronically exposed to excess free fatty acids (FFA), as occurs in vivo in type 2 diabetes. To determine whether chronic low-grade activation of AMP-activated kinase (AMPK) improves substrate metabolism in cardiomyocytes exposed to FFA, isolated cultured cardiomyocytes were exposed for 7 days to FFA ± the AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Glucose transport and glycolysis were then measured during acute metabolic stress provoked by oligomycin. Chronic treatment with AICAR improved basal and oligomycin-stimulated glucose transport in FFA-exposed but not in control cardiomyocytes. Similarly, basal and oligomycin-stimulated glycolysis was reduced in FFA-exposed cardiomyocytes but restored by chronic AICAR treatment. Conversely, fatty acid oxidation was increased in FFA-exposed cardiomyocytes and reduced by chronic AICAR treatment. Chronic AICAR treatment induced in FFA-exposed cardiomyocytes the biogenesis of numerous lipid droplets. Curiously, whereas acute treatment of cardiomyocytes with AICAR increased phosphorylation of the AMPKα subunit on T

Indexed as

Aminoimidazole CarboxamideAMP-Activated Protein KinasesAnimalsBiological TransportDiabetes Mellitus, Type 2Fatty Acids, NonesterifiedGlucoseGlycolysisHypoglycemic AgentsMaleMyocytes, CardiacPhosphorylationRatsRats, Sprague-DawleyRibonucleotidesAICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein KinasesFatty Acids, NonesterifiedGlucoseHypoglycemic AgentsRibonucleotidesAMP-activated protein kinase (AMPK)CardiomyocytesGlucose metabolismHyperlipidemia

Identifiers

PMID31152240
OpenAlexW2947934958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.